These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1494 related items for PubMed ID: 15657416

  • 1. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD.
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD.
    Cardiovasc Res; 2004 Aug 15; 63(3):467-75. PubMed ID: 15276472
    [Abstract] [Full Text] [Related]

  • 3. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.
    Dai YS, Xu J, Molkentin JD.
    Mol Cell Biol; 2005 Nov 15; 25(22):9936-48. PubMed ID: 16260608
    [Abstract] [Full Text] [Related]

  • 4. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B, Wollert KC.
    Cardiovasc Res; 2004 Aug 15; 63(3):450-7. PubMed ID: 15276470
    [Abstract] [Full Text] [Related]

  • 5. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD.
    J Clin Invest; 2003 May 15; 111(10):1475-86. PubMed ID: 12750397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA.
    Oncogene; 2007 Feb 08; 26(6):813-21. PubMed ID: 16909118
    [Abstract] [Full Text] [Related]

  • 8. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V, Izaddoustdar F, Martinez-Abundis E, Karmazyn M.
    Cell Signal; 2012 Dec 08; 24(12):2283-90. PubMed ID: 22917533
    [Abstract] [Full Text] [Related]

  • 9. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ, Molkentin JD.
    Biochem Biophys Res Commun; 2004 Oct 01; 322(4):1178-91. PubMed ID: 15336966
    [Abstract] [Full Text] [Related]

  • 10. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C, Klingebiel TM, Grau SP, Toischer K, Didié M, Jacobshagen C, Dullin C, Hasenfuss G, Seidler T.
    Cardiovasc Res; 2011 Jun 01; 90(3):521-8. PubMed ID: 21273244
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
    Xiao L, Coutu P, Villeneuve LR, Tadevosyan A, Maguy A, Le Bouter S, Allen BG, Nattel S.
    Circ Res; 2008 Sep 26; 103(7):733-42. PubMed ID: 18723449
    [Abstract] [Full Text] [Related]

  • 12. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
    Pu WT, Ma Q, Izumo S.
    Circ Res; 2003 Apr 18; 92(7):725-31. PubMed ID: 12663489
    [Abstract] [Full Text] [Related]

  • 13. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
    Obasanjo-Blackshire K, Mesquita R, Jabr RI, Molkentin JD, Hart SL, Marber MS, Xia Y, Heads RJ.
    Cardiovasc Res; 2006 Sep 01; 71(4):672-83. PubMed ID: 16828070
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD.
    Circ Res; 2004 Jan 09; 94(1):110-8. PubMed ID: 14656927
    [Abstract] [Full Text] [Related]

  • 15. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.
    Szokodi I, Kerkelä R, Kubin AM, Sármán B, Pikkarainen S, Kónyi A, Horváth IG, Papp L, Tóth M, Skoumal R, Ruskoaho H.
    Circulation; 2008 Oct 14; 118(16):1651-8. PubMed ID: 18824646
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
    Du MR, Zhou WH, Dong L, Zhu XY, He YY, Yang JY, Li DJ.
    Biol Reprod; 2008 Jun 14; 78(6):1102-10. PubMed ID: 18322274
    [Abstract] [Full Text] [Related]

  • 17. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN.
    J Clin Invest; 2000 May 14; 105(10):1395-406. PubMed ID: 10811847
    [Abstract] [Full Text] [Related]

  • 18. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
    Muckenfuss H, Hamdorf M, Avots A, Sanzenbacher R, Tschulena U, Cichutek K, Flory E.
    Mol Immunol; 2006 Mar 14; 43(8):1172-82. PubMed ID: 16125242
    [Abstract] [Full Text] [Related]

  • 19. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
    Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M, Yamashita T, Ishido S, Hotta H, Yokoyama M.
    J Mol Cell Cardiol; 2000 Jun 14; 32(6):947-60. PubMed ID: 10888249
    [Abstract] [Full Text] [Related]

  • 20. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D.
    Cancer Res; 2006 Feb 01; 66(3):1320-6. PubMed ID: 16452185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.